US · Healthcare · Medical Care Facilities
EPS came in at 0.06 against a street estimate of 0.09 — a miss of 33.3%.
Analysts rate InnovAge Holding Corp a hold (1 buy, 1 hold, 1 sell out of 3) with an average price target of $12.00.
CONFIDENT InnovAge delivered 175% EBITDA growth in FY26 and is entering a scaled growth phase (InnovAge 3.0). FY27 guidance is inline with street; margin discipline prioritized as rate growth moderates. Quality and compliance remain non-negotiable. Q4 FY26 California and Colorado (70% of census) represent the largest concentration risk; final rate outcomes for both states pending as of call date. Call did not include analyst Q&A segment; Q&A portion was not transcribed or was not part of this earnings call excerpt. 2026-09-08…
Full summary in the app.
| Fund | Stake |
|---|---|
| T. Rowe Price Investment Management,Inc. | 4.49% |
| Federated Hermes Inc | 1.40% |
| BlackRock Inc | 1.09% |
| Vanguard Capital Management, LLC | 0.69% |
| Arrowstreet Capital Limited Partnership | 0.49% |
| Algert Global LLC | 0.46% |
| Geode Capital Management, LLC | 0.44% |
| State Street Corp | 0.34% |
| Document | Date |
|---|---|
| Company announcement · Q1 FY2027 INNOVAGE HOLDING CORP. (INNV) - FORM 8-K SUMMARY HEADLINE NUMBERS • Secondary offering of 10,000,000 shares at $9.25 per share completed September 2 | 2026-09-24 |
| Annual report FY2026 INNOVAGE HOLDING CORP. - FORM 10-K SUMMARY FOR RETAIL INVESTORS --- HEADLINE NUMBERS • Participants served: 8,230 PACE participants as of June 30, | 2026-09-09 |
| Results announced · Q1 FY2027 INNOVAGE HOLDING CORP. - FINANCIAL RESULTS SUMMARY HEADLINE NUMBERS • Total revenues FY2026: $989.7 million, up 15.9% from $853.7 million FY2025 • N | 2026-09-08 |
| Reg FD disclosure · Q4 FY2026 INNOVAGE HOLDING CORP (INNV) - FORM 8-K SUMMARY HEADLINE NUMBERS • No specific financial metrics disclosed in this filing • Document is a Regulation | 2026-05-18 |
| Board / officer change · Q4 FY2026 INNOVAGE HOLDING CORP. (INNV) - FORM 8-K SUMMARY BUSINESS & SEGMENT HIGHLIGHTS • InnovAge Holding Corp. appointed Jennifer Browne as President and C | 2026-05-12 |
| Quarterly report · Q3 FY2026 INNOVAGE HOLDING CORP. - Q1 FY2026 SUMMARY HEADLINE NUMBERS • Revenue (9 months ended March 31, 2026): $727.8 million vs. $632.3 million prior year | 2026-05-08 |
| Results announced · Q4 FY2026 INNOVAGE HOLDING CORP. - Q3 FY2026 FINANCIAL SUMMARY HEADLINE NUMBERS • Total Revenues Q3 2026: $251.9 million, up 15.5% from $218.1 million in Q3 2 | 2026-05-05 |
| Quarterly report · Q2 FY2026 INNOVAGE HOLDING CORP. - Q2 FY2026 10-Q SUMMARY HEADLINE NUMBERS • Total Revenues (6 months): $475.8 million (up from $414.1 million in prior year, | 2026-02-03 |
Readable in the app.
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for InnovAge Holding Corp — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-10-18.